View Future GrowthBio Planet 과거 순이익 실적과거 기준 점검 5/6Bio Planet은 연평균 6.8%의 비율로 수입이 증가해 온 반면, Consumer Retailing 산업은 수입이 6.8% 증가했습니다. 매출은 연평균 10.5%의 비율로 증가했습니다. Bio Planet의 자기자본이익률은 18.8%이고 순이익률은 2%입니다.핵심 정보6.79%순이익 성장률4.12%주당순이익(EPS) 성장률Consumer Retailing 산업 성장률10.52%매출 성장률10.45%자기자본이익률18.77%순이익률2.00%다음 순이익 업데이트25 Sep 2026최근 과거 실적 업데이트공고 • Aug 22Bio Planet S.A. to Report First Half, 2025 Results on Sep 25, 2025Bio Planet S.A. announced that they will report first half, 2025 results on Sep 25, 2025Reported Earnings • Oct 01Second quarter 2024 earnings releasedSecond quarter 2024 results: Revenue: zł63.8m (up 5.0% from 2Q 2023). Net income: zł47.0k (down 88% from 2Q 2023). Profit margin: 0.1% (down from 0.6% in 2Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 76 percentage points per year, which is a significant difference in performance.Reported Earnings • May 29First quarter 2024 earnings releasedFirst quarter 2024 results: Revenue: zł76.3m (up 11% from 1Q 2023). Net income: zł1.26m (down 2.1% from 1Q 2023). Profit margin: 1.7% (down from 1.9% in 1Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 70 percentage points per year, which is a significant difference in performance.Reported Earnings • Apr 26Full year 2023 earnings releasedFull year 2023 results: Revenue: zł254.5m (up 26% from FY 2022). Net income: zł945.0k (up 63% from FY 2022). Profit margin: 0.4% (up from 0.3% in FY 2022). The increase in margin was driven by higher revenue.공고 • Dec 09+ 3 more updatesBio Planet S.A. to Report Q1, 2024 Results on May 24, 2024Bio Planet S.A. announced that they will report Q1, 2024 results on May 24, 2024Reported Earnings • Nov 27Third quarter 2023 earnings releasedThird quarter 2023 results: Revenue: zł56.9m (up 25% from 3Q 2022). Net loss: zł932.0k (loss narrowed 16% from 3Q 2022).모든 업데이트 보기Recent updatesUpcoming Dividend • Jun 16Upcoming dividend of zł0.63 per shareEligible shareholders must have bought the stock before 23 June 2026. Payment date: 18 September 2026. Payout ratio is a comfortable 29% but the company is not cash flow positive. Trailing yield: 2.0%. Lower than top quartile of German dividend payers (4.7%). Lower than average of industry peers (3.6%).Valuation Update With 7 Day Price Move • Jun 04Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to €6.08, the stock trades at a trailing P/E ratio of 15.4x. Average trailing P/E is 19x in the Consumer Retailing industry in Europe. Total returns to shareholders of 104% over the past three years.New Risk • May 28New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 15% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (15% operating cash flow to total debt). Share price has been highly volatile over the past 3 months (18% average weekly change). Earnings have declined by 19% per year over the past 5 years. Minor Risks Dividend is not well covered by cash flows (256% cash payout ratio). Market cap is less than US$100m (€22.7m market cap, or US$26.4m).공고 • Apr 22Bio Planet S.A., Annual General Meeting, May 15, 2026Bio Planet S.A., Annual General Meeting, May 15, 2026, at 10:00 Central European Standard Time.공고 • Apr 21Bio Planet S.A. announces Annual dividend, payable on September 18, 2026Bio Planet S.A. announced Annual dividend of PLN 0.6300 per share payable on September 18, 2026, ex-date on June 23, 2026 and record date on June 24, 2026.공고 • Aug 22Bio Planet S.A. to Report First Half, 2025 Results on Sep 25, 2025Bio Planet S.A. announced that they will report first half, 2025 results on Sep 25, 2025공고 • Jun 01Bio Planet S.A. announces Annual dividend, payable on July 28, 2025Bio Planet S.A. announced Annual dividend of PLN 0.1000 per share payable on July 28, 2025, ex-date on July 11, 2025 and record date on July 14, 2025.New Risk • Nov 12New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.9x net interest cover). Earnings have declined by 27% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (6.9% average weekly change). Market cap is less than US$100m (€11.2m market cap, or US$11.9m).New Risk • Oct 06New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 0.9x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.9x net interest cover). Earnings have declined by 27% per year over the past 5 years. Minor Risk Market cap is less than US$100m (€12.3m market cap, or US$13.5m).Reported Earnings • Oct 01Second quarter 2024 earnings releasedSecond quarter 2024 results: Revenue: zł63.8m (up 5.0% from 2Q 2023). Net income: zł47.0k (down 88% from 2Q 2023). Profit margin: 0.1% (down from 0.6% in 2Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 76 percentage points per year, which is a significant difference in performance.Reported Earnings • May 29First quarter 2024 earnings releasedFirst quarter 2024 results: Revenue: zł76.3m (up 11% from 1Q 2023). Net income: zł1.26m (down 2.1% from 1Q 2023). Profit margin: 1.7% (down from 1.9% in 1Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 70 percentage points per year, which is a significant difference in performance.Reported Earnings • Apr 26Full year 2023 earnings releasedFull year 2023 results: Revenue: zł254.5m (up 26% from FY 2022). Net income: zł945.0k (up 63% from FY 2022). Profit margin: 0.4% (up from 0.3% in FY 2022). The increase in margin was driven by higher revenue.공고 • Dec 09+ 3 more updatesBio Planet S.A. to Report Q1, 2024 Results on May 24, 2024Bio Planet S.A. announced that they will report Q1, 2024 results on May 24, 2024Valuation Update With 7 Day Price Move • Dec 07Investor sentiment improves as stock rises 19%After last week's 19% share price gain to €2.78, the stock trades at a trailing P/E ratio of 63.7x. Average trailing P/E is 14x in the Consumer Retailing industry in Europe. Total returns to shareholders of 39% over the past year.Reported Earnings • Nov 27Third quarter 2023 earnings releasedThird quarter 2023 results: Revenue: zł56.9m (up 25% from 3Q 2022). Net loss: zł932.0k (loss narrowed 16% from 3Q 2022).New Risk • Sep 26New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 0.7x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.7x net interest cover). Share price has been highly volatile over the past 3 months (9.1% average weekly change). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.2% net profit margin). Market cap is less than US$100m (€10.4m market cap, or US$10.9m).Reported Earnings • Sep 23Second quarter 2023 earnings releasedSecond quarter 2023 results: Revenue: zł60.7m (up 30% from 2Q 2022). Net income: zł394.0k (up zł529.0k from 2Q 2022). Profit margin: 0.6% (up from net loss in 2Q 2022).New Risk • Jun 15New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 1.1x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.1x net interest cover). Market cap is less than US$10m (€8.28m market cap, or US$9.05m). Minor Risk Share price has been volatile over the past 3 months (9.2% average weekly change).New Risk • Jun 11New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €9.12m (US$9.80m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (€9.12m market cap, or US$9.80m). Minor Risk Share price has been volatile over the past 3 months (9.0% average weekly change).공고 • May 27Bio Planet S.A., Annual General Meeting, Jun 21, 2023Bio Planet S.A., Annual General Meeting, Jun 21, 2023, at 10:00 Central European Standard Time.Valuation Update With 7 Day Price Move • May 15Investor sentiment improves as stock rises 17%After last week's 17% share price gain to €3.04, the stock trades at a trailing P/E ratio of 77.5x. Average trailing P/E is 16x in the Consumer Retailing industry in Europe. Total returns to shareholders of 22% over the past year.Reported Earnings • Apr 21Full year 2022 earnings releasedFull year 2022 results: Revenue: zł201.5m (down 1.9% from FY 2021). Net income: zł581.0k (down 84% from FY 2021). Profit margin: 0.3% (down from 1.8% in FY 2021).Valuation Update With 7 Day Price Move • Feb 07Investor sentiment improves as stock rises 26%After last week's 26% share price gain to €2.63, the stock trades at a trailing P/E ratio of 77.8x. Average trailing P/E is 14x in the Consumer Retailing industry in Europe. Total loss to shareholders of 46% over the past year.Valuation Update With 7 Day Price Move • Jan 21Investor sentiment improved over the past weekAfter last week's 17% share price gain to €2.33, the stock trades at a trailing P/E ratio of 69.2x. Average trailing P/E is 14x in the Consumer Retailing industry in Europe. Total loss to shareholders of 56% over the past year.공고 • Jan 12+ 3 more updatesBio Planet S.A. to Report Q1, 2023 Results on May 26, 2023Bio Planet S.A. announced that they will report Q1, 2023 results on May 26, 2023Reported Earnings • Nov 27Third quarter 2022 earnings releasedThird quarter 2022 results: Revenue: zł45.5m (up 4.2% from 3Q 2021). Net loss: zł1.11m (down zł1.28m from profit in 3Q 2021).Valuation Update With 7 Day Price Move • Nov 17Investor sentiment improved over the past weekAfter last week's 19% share price gain to €2.19, the stock trades at a trailing P/E ratio of 18.8x. Average trailing P/E is 13x in the Consumer Retailing industry in Europe. Total loss to shareholders of 65% over the past year.Valuation Update With 7 Day Price Move • Oct 25Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to €1.68, the stock trades at a trailing P/E ratio of 14.5x. Average trailing P/E is 13x in the Consumer Retailing industry in Europe. Total loss to shareholders of 74% over the past year.공고 • Sep 28Bio Pole Spolka Z Ograniczona Odpowiedzialnoscia acquired 8% stake in Bio Planet S.A. (WSE:BIP) from ORGANIC Farma Zdrowia S.A. (WSE:ORG).Bio Pole Spolka Z Ograniczona Odpowiedzialnoscia acquired 8% stake in Bio Planet S.A. (WSE:BIP) from ORGANIC Farma Zdrowia S.A. (WSE:ORG) on September 26, 2022.Bio Pole Spolka Z Ograniczona Odpowiedzialnoscia completed the acquisition of 8% stake in Bio Planet S.A. (WSE:BIP) from ORGANIC Farma Zdrowia S.A. (WSE:ORG) on September 26, 2022.Reported Earnings • Sep 25Second quarter 2022 earnings releasedSecond quarter 2022 results: Revenue: zł46.7m (down 4.4% from 2Q 2021). Net loss: zł135.0k (down 116% from profit in 2Q 2021).Valuation Update With 7 Day Price Move • Sep 01Investor sentiment improved over the past weekAfter last week's 42% share price gain to €2.97, the stock trades at a trailing P/E ratio of 16.3x. Average trailing P/E is 13x in the Consumer Retailing industry in Europe. Total loss to shareholders of 48% over the past year.Upcoming Dividend • Jul 29Upcoming dividend of zł0.36 per shareEligible shareholders must have bought the stock before 05 August 2022. Payment date: 22 August 2022. Trailing yield: 3.1%. Lower than top quartile of German dividend payers (4.5%). Lower than average of industry peers (4.4%).Valuation Update With 7 Day Price Move • Jun 04Investor sentiment improved over the past weekAfter last week's 17% share price gain to €2.91, the stock trades at a trailing P/E ratio of 9.3x. Average trailing P/E is 13x in the Consumer Retailing industry in Europe. Total loss to shareholders of 63% over the past year.공고 • May 20Bio Planet S.A., Annual General Meeting, Jun 14, 2022Bio Planet S.A., Annual General Meeting, Jun 14, 2022, at 10:00 Central European Standard Time.Valuation Update With 7 Day Price Move • May 03Investor sentiment deteriorated over the past weekAfter last week's 24% share price decline to €3.08, the stock trades at a trailing P/E ratio of 10.4x. Average trailing P/E is 14x in the Consumer Retailing industry in Europe.Reported Earnings • Nov 10Third quarter 2021 earnings releasedThe company reported a poor third quarter result with weaker earnings, revenues and profit margins. Third quarter 2021 results: Revenue: zł43.6m (down 2.0% from 3Q 2020). Net income: zł165.0k (down 68% from 3Q 2020). Profit margin: 0.4% (down from 1.1% in 3Q 2020). The decrease in margin was driven by lower revenue.Reported Earnings • Nov 10Third quarter 2021 earnings releasedThe company reported a poor third quarter result with weaker earnings, revenues and profit margins. Third quarter 2021 results: Revenue: zł43.6m (down 2.0% from 3Q 2020). Net income: zł165.0k (down 68% from 3Q 2020). Profit margin: 0.4% (down from 1.1% in 3Q 2020). The decrease in margin was driven by lower revenue.Valuation Update With 7 Day Price Move • Jul 18Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to zł6.30, the stock trades at a trailing P/E ratio of 15.4x. Average trailing P/E is 20x in the Consumer Retailing industry in Europe.매출 및 비용 세부 내역Bio Planet가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이DB:8WS 매출, 비용 및 순이익 (PLN Millions)날짜매출순이익일반관리비연구개발비31 Mar 26321678031 Dec 25311676030 Sep 25302574030 Jun 25293473031 Mar 25284372031 Dec 24279272030 Sep 24272170030 Jun 24265168031 Mar 24262167031 Dec 23255163030 Sep 23240158030 Jun 23228055031 Mar 23214052031 Dec 22201148030 Sep 22202048030 Jun 22201247031 Mar 22203347031 Dec 21205447030 Sep 21205547030 Jun 21206547031 Mar 21207646031 Dec 20204545030 Sep 20191541030 Jun 20181439031 Mar 20168336031 Dec 19153234030 Sep 19146132030 Jun 19141131031 Mar 19134029031 Dec 18128028030 Sep 18126028030 Jun 18125027031 Mar 18125027031 Dec 17123126030 Sep 17121125030 Jun 17121224031 Mar 17119223031 Dec 16113122030 Sep 16108122030 Jun 16102121031 Mar 1694120031 Dec 1586218030 Sep 15792170양질의 수익: 8WS는 고품질 수익을 보유하고 있습니다.이익 마진 증가: 8WS의 현재 순 이익률 (2%)은 지난해 (1.1%)보다 높습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: 8WS의 수익은 지난 5년 동안 연평균 6.8% 증가했습니다.성장 가속화: 지난 1년간 8WS 의 수익 증가율(104.8%)은 연간 평균(6.8%)을 초과합니다.수익 대 산업: 8WS의 지난 1년 수익 증가율(104.8%)은 Consumer Retailing 업계의 2.8%를 상회했습니다.자기자본이익률높은 ROE: 8WS의 자본 수익률(18.8%)은 낮음으로 평가됩니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YConsumer-retailing 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/07/15 14:50종가2026/07/15 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Bio Planet S.A.는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공고 • Aug 22Bio Planet S.A. to Report First Half, 2025 Results on Sep 25, 2025Bio Planet S.A. announced that they will report first half, 2025 results on Sep 25, 2025
Reported Earnings • Oct 01Second quarter 2024 earnings releasedSecond quarter 2024 results: Revenue: zł63.8m (up 5.0% from 2Q 2023). Net income: zł47.0k (down 88% from 2Q 2023). Profit margin: 0.1% (down from 0.6% in 2Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 76 percentage points per year, which is a significant difference in performance.
Reported Earnings • May 29First quarter 2024 earnings releasedFirst quarter 2024 results: Revenue: zł76.3m (up 11% from 1Q 2023). Net income: zł1.26m (down 2.1% from 1Q 2023). Profit margin: 1.7% (down from 1.9% in 1Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 70 percentage points per year, which is a significant difference in performance.
Reported Earnings • Apr 26Full year 2023 earnings releasedFull year 2023 results: Revenue: zł254.5m (up 26% from FY 2022). Net income: zł945.0k (up 63% from FY 2022). Profit margin: 0.4% (up from 0.3% in FY 2022). The increase in margin was driven by higher revenue.
공고 • Dec 09+ 3 more updatesBio Planet S.A. to Report Q1, 2024 Results on May 24, 2024Bio Planet S.A. announced that they will report Q1, 2024 results on May 24, 2024
Reported Earnings • Nov 27Third quarter 2023 earnings releasedThird quarter 2023 results: Revenue: zł56.9m (up 25% from 3Q 2022). Net loss: zł932.0k (loss narrowed 16% from 3Q 2022).
Upcoming Dividend • Jun 16Upcoming dividend of zł0.63 per shareEligible shareholders must have bought the stock before 23 June 2026. Payment date: 18 September 2026. Payout ratio is a comfortable 29% but the company is not cash flow positive. Trailing yield: 2.0%. Lower than top quartile of German dividend payers (4.7%). Lower than average of industry peers (3.6%).
Valuation Update With 7 Day Price Move • Jun 04Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to €6.08, the stock trades at a trailing P/E ratio of 15.4x. Average trailing P/E is 19x in the Consumer Retailing industry in Europe. Total returns to shareholders of 104% over the past three years.
New Risk • May 28New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 15% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (15% operating cash flow to total debt). Share price has been highly volatile over the past 3 months (18% average weekly change). Earnings have declined by 19% per year over the past 5 years. Minor Risks Dividend is not well covered by cash flows (256% cash payout ratio). Market cap is less than US$100m (€22.7m market cap, or US$26.4m).
공고 • Apr 22Bio Planet S.A., Annual General Meeting, May 15, 2026Bio Planet S.A., Annual General Meeting, May 15, 2026, at 10:00 Central European Standard Time.
공고 • Apr 21Bio Planet S.A. announces Annual dividend, payable on September 18, 2026Bio Planet S.A. announced Annual dividend of PLN 0.6300 per share payable on September 18, 2026, ex-date on June 23, 2026 and record date on June 24, 2026.
공고 • Aug 22Bio Planet S.A. to Report First Half, 2025 Results on Sep 25, 2025Bio Planet S.A. announced that they will report first half, 2025 results on Sep 25, 2025
공고 • Jun 01Bio Planet S.A. announces Annual dividend, payable on July 28, 2025Bio Planet S.A. announced Annual dividend of PLN 0.1000 per share payable on July 28, 2025, ex-date on July 11, 2025 and record date on July 14, 2025.
New Risk • Nov 12New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.9x net interest cover). Earnings have declined by 27% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (6.9% average weekly change). Market cap is less than US$100m (€11.2m market cap, or US$11.9m).
New Risk • Oct 06New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 0.9x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.9x net interest cover). Earnings have declined by 27% per year over the past 5 years. Minor Risk Market cap is less than US$100m (€12.3m market cap, or US$13.5m).
Reported Earnings • Oct 01Second quarter 2024 earnings releasedSecond quarter 2024 results: Revenue: zł63.8m (up 5.0% from 2Q 2023). Net income: zł47.0k (down 88% from 2Q 2023). Profit margin: 0.1% (down from 0.6% in 2Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 76 percentage points per year, which is a significant difference in performance.
Reported Earnings • May 29First quarter 2024 earnings releasedFirst quarter 2024 results: Revenue: zł76.3m (up 11% from 1Q 2023). Net income: zł1.26m (down 2.1% from 1Q 2023). Profit margin: 1.7% (down from 1.9% in 1Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 70 percentage points per year, which is a significant difference in performance.
Reported Earnings • Apr 26Full year 2023 earnings releasedFull year 2023 results: Revenue: zł254.5m (up 26% from FY 2022). Net income: zł945.0k (up 63% from FY 2022). Profit margin: 0.4% (up from 0.3% in FY 2022). The increase in margin was driven by higher revenue.
공고 • Dec 09+ 3 more updatesBio Planet S.A. to Report Q1, 2024 Results on May 24, 2024Bio Planet S.A. announced that they will report Q1, 2024 results on May 24, 2024
Valuation Update With 7 Day Price Move • Dec 07Investor sentiment improves as stock rises 19%After last week's 19% share price gain to €2.78, the stock trades at a trailing P/E ratio of 63.7x. Average trailing P/E is 14x in the Consumer Retailing industry in Europe. Total returns to shareholders of 39% over the past year.
Reported Earnings • Nov 27Third quarter 2023 earnings releasedThird quarter 2023 results: Revenue: zł56.9m (up 25% from 3Q 2022). Net loss: zł932.0k (loss narrowed 16% from 3Q 2022).
New Risk • Sep 26New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 0.7x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.7x net interest cover). Share price has been highly volatile over the past 3 months (9.1% average weekly change). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.2% net profit margin). Market cap is less than US$100m (€10.4m market cap, or US$10.9m).
Reported Earnings • Sep 23Second quarter 2023 earnings releasedSecond quarter 2023 results: Revenue: zł60.7m (up 30% from 2Q 2022). Net income: zł394.0k (up zł529.0k from 2Q 2022). Profit margin: 0.6% (up from net loss in 2Q 2022).
New Risk • Jun 15New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 1.1x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.1x net interest cover). Market cap is less than US$10m (€8.28m market cap, or US$9.05m). Minor Risk Share price has been volatile over the past 3 months (9.2% average weekly change).
New Risk • Jun 11New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €9.12m (US$9.80m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (€9.12m market cap, or US$9.80m). Minor Risk Share price has been volatile over the past 3 months (9.0% average weekly change).
공고 • May 27Bio Planet S.A., Annual General Meeting, Jun 21, 2023Bio Planet S.A., Annual General Meeting, Jun 21, 2023, at 10:00 Central European Standard Time.
Valuation Update With 7 Day Price Move • May 15Investor sentiment improves as stock rises 17%After last week's 17% share price gain to €3.04, the stock trades at a trailing P/E ratio of 77.5x. Average trailing P/E is 16x in the Consumer Retailing industry in Europe. Total returns to shareholders of 22% over the past year.
Reported Earnings • Apr 21Full year 2022 earnings releasedFull year 2022 results: Revenue: zł201.5m (down 1.9% from FY 2021). Net income: zł581.0k (down 84% from FY 2021). Profit margin: 0.3% (down from 1.8% in FY 2021).
Valuation Update With 7 Day Price Move • Feb 07Investor sentiment improves as stock rises 26%After last week's 26% share price gain to €2.63, the stock trades at a trailing P/E ratio of 77.8x. Average trailing P/E is 14x in the Consumer Retailing industry in Europe. Total loss to shareholders of 46% over the past year.
Valuation Update With 7 Day Price Move • Jan 21Investor sentiment improved over the past weekAfter last week's 17% share price gain to €2.33, the stock trades at a trailing P/E ratio of 69.2x. Average trailing P/E is 14x in the Consumer Retailing industry in Europe. Total loss to shareholders of 56% over the past year.
공고 • Jan 12+ 3 more updatesBio Planet S.A. to Report Q1, 2023 Results on May 26, 2023Bio Planet S.A. announced that they will report Q1, 2023 results on May 26, 2023
Reported Earnings • Nov 27Third quarter 2022 earnings releasedThird quarter 2022 results: Revenue: zł45.5m (up 4.2% from 3Q 2021). Net loss: zł1.11m (down zł1.28m from profit in 3Q 2021).
Valuation Update With 7 Day Price Move • Nov 17Investor sentiment improved over the past weekAfter last week's 19% share price gain to €2.19, the stock trades at a trailing P/E ratio of 18.8x. Average trailing P/E is 13x in the Consumer Retailing industry in Europe. Total loss to shareholders of 65% over the past year.
Valuation Update With 7 Day Price Move • Oct 25Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to €1.68, the stock trades at a trailing P/E ratio of 14.5x. Average trailing P/E is 13x in the Consumer Retailing industry in Europe. Total loss to shareholders of 74% over the past year.
공고 • Sep 28Bio Pole Spolka Z Ograniczona Odpowiedzialnoscia acquired 8% stake in Bio Planet S.A. (WSE:BIP) from ORGANIC Farma Zdrowia S.A. (WSE:ORG).Bio Pole Spolka Z Ograniczona Odpowiedzialnoscia acquired 8% stake in Bio Planet S.A. (WSE:BIP) from ORGANIC Farma Zdrowia S.A. (WSE:ORG) on September 26, 2022.Bio Pole Spolka Z Ograniczona Odpowiedzialnoscia completed the acquisition of 8% stake in Bio Planet S.A. (WSE:BIP) from ORGANIC Farma Zdrowia S.A. (WSE:ORG) on September 26, 2022.
Reported Earnings • Sep 25Second quarter 2022 earnings releasedSecond quarter 2022 results: Revenue: zł46.7m (down 4.4% from 2Q 2021). Net loss: zł135.0k (down 116% from profit in 2Q 2021).
Valuation Update With 7 Day Price Move • Sep 01Investor sentiment improved over the past weekAfter last week's 42% share price gain to €2.97, the stock trades at a trailing P/E ratio of 16.3x. Average trailing P/E is 13x in the Consumer Retailing industry in Europe. Total loss to shareholders of 48% over the past year.
Upcoming Dividend • Jul 29Upcoming dividend of zł0.36 per shareEligible shareholders must have bought the stock before 05 August 2022. Payment date: 22 August 2022. Trailing yield: 3.1%. Lower than top quartile of German dividend payers (4.5%). Lower than average of industry peers (4.4%).
Valuation Update With 7 Day Price Move • Jun 04Investor sentiment improved over the past weekAfter last week's 17% share price gain to €2.91, the stock trades at a trailing P/E ratio of 9.3x. Average trailing P/E is 13x in the Consumer Retailing industry in Europe. Total loss to shareholders of 63% over the past year.
공고 • May 20Bio Planet S.A., Annual General Meeting, Jun 14, 2022Bio Planet S.A., Annual General Meeting, Jun 14, 2022, at 10:00 Central European Standard Time.
Valuation Update With 7 Day Price Move • May 03Investor sentiment deteriorated over the past weekAfter last week's 24% share price decline to €3.08, the stock trades at a trailing P/E ratio of 10.4x. Average trailing P/E is 14x in the Consumer Retailing industry in Europe.
Reported Earnings • Nov 10Third quarter 2021 earnings releasedThe company reported a poor third quarter result with weaker earnings, revenues and profit margins. Third quarter 2021 results: Revenue: zł43.6m (down 2.0% from 3Q 2020). Net income: zł165.0k (down 68% from 3Q 2020). Profit margin: 0.4% (down from 1.1% in 3Q 2020). The decrease in margin was driven by lower revenue.
Reported Earnings • Nov 10Third quarter 2021 earnings releasedThe company reported a poor third quarter result with weaker earnings, revenues and profit margins. Third quarter 2021 results: Revenue: zł43.6m (down 2.0% from 3Q 2020). Net income: zł165.0k (down 68% from 3Q 2020). Profit margin: 0.4% (down from 1.1% in 3Q 2020). The decrease in margin was driven by lower revenue.
Valuation Update With 7 Day Price Move • Jul 18Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to zł6.30, the stock trades at a trailing P/E ratio of 15.4x. Average trailing P/E is 20x in the Consumer Retailing industry in Europe.